Brief Behavioral Therapy for Insomnia in Substance Use Recovery
(BBTI_SUDs Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if treating sleep problems can help individuals in substance abuse recovery programs remain in treatment longer. It tests a sleep-focused therapy called Brief Behavioral Therapy for Insomnia (BBTI) alongside standard care, compared to standard care alone. Individuals diagnosed with insomnia and actively dealing with substance use issues might be suitable candidates. Participants will wear a sleep-tracking watch, complete surveys, and maintain a sleep diary to help researchers assess the treatment's impact. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance recovery outcomes for many.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this behavioral therapy is safe for individuals in substance use recovery?
Research has shown that Brief Behavioral Therapy for Insomnia (BBTI) is a well-accepted treatment for sleep problems, even for individuals with substance use disorders. Studies have found that BBTI improves sleep by changing sleep habits and practicing relaxation techniques.
Participants often report that BBTI is safe and doesn't cause serious side effects, which is crucial for those considering a clinical trial. Since the treatment doesn't involve medication, it typically results in fewer negative side effects.
Past research has demonstrated that BBTI is safe for various groups, including those with other mental health issues. This suggests it’s a gentle way to improve sleep without causing extra stress. For those considering a trial that includes BBTI, these findings indicate it's a promising and safe option.12345Why are researchers excited about this trial?
Researchers are excited about Brief Behavioral Therapy for Insomnia (BBTI) because it offers a fresh approach to tackling insomnia in individuals recovering from substance use. Unlike standard treatments that often rely on medication, BBTI focuses on behavioral techniques, providing four in-person sessions that equip participants with practical strategies to improve their sleep patterns. This method is particularly promising because it avoids potential interactions with substances and can empower individuals with skills that support long-term recovery and sleep improvement.
What evidence suggests that Brief Behavioral Therapy for Insomnia might be an effective treatment for sleep problems in substance use recovery?
Research has shown that Brief Behavioral Therapy for Insomnia (BBTI) can improve sleep problems. Studies have found BBTI effective in reducing insomnia symptoms in cannabis users and potentially beneficial for those with other substance use issues. Participants in these studies often reported better sleep and fewer substance use problems after BBTI. In this trial, participants in the BBTI Group will receive structured sessions focused on improving sleep habits and behaviors, making it a potentially helpful tool for managing insomnia during substance use recovery. This suggests BBTI might help individuals remain in recovery programs longer by addressing their sleep issues.36789
Who Is on the Research Team?
Traci J Speed, MD/PHD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults over 18 with substance use disorders and insomnia, receiving care at specific clinics. They must have an Insomnia Severity Index score of 8+ and a diagnosis of insomnia. Excluded are those with severe medical/psychiatric issues, acute alcohol withdrawal, pregnant/breastfeeding women, or certain sleep conditions like severe apnea.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Brief Behavioral Therapy for Insomnia (BBTI) over 4 weeks, including 4 in-person sessions and completing sleep diaries.
Follow-up
Participants are monitored for changes in sleep efficiency and other outcomes, wearing a sleep watch for 2 weeks post-treatment.
Maintenance
Maintenance of intervention is assessed over one year to evaluate long-term feasibility and adoption.
What Are the Treatments Tested in This Trial?
Interventions
- Brief Behavioral Therapy for Insomnia (BBTI)
Brief Behavioral Therapy for Insomnia (BBTI) is already approved in United States, European Union for the following indications:
- Insomnia
- Substance Use Disorder recovery support
- Insomnia
- Comorbid psychiatric, medical, or sleep disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
American Academy of Sleep Medicine
Collaborator